德睿智药（MindRank）

MindRank and Borui Cuanghe have announced a strategic collaboration to advance AI-driven radionuclide drug conjugates (RDCs) that use cyclic peptides as targeting ligands, aimed at unmet needs in precision oncology. MindRank contributes its Intera life-science foundation model system, with InteraFold-PEP predicting how cyclic peptides bind target proteins to guide design, screening and optimization; Borui Cuanghe contributes radiopharmaceutical development, radiolabeling and clinical translation, and the two sides iterate AI design against experimental validation. The target ligands must combine high affinity, high selectivity and good developability, and the work is at the collaboration-launch stage.

MindRank and Borui Cuanghe have announced a strategic collaboration to advance AI-driven radionuclide drug conjugates (RDCs) that use cyclic peptides as targeting ligands, aimed at unmet needs in precision oncology. MindRank contributes its Intera life-science foundation model system, with InteraFold-PEP predicting how cyclic peptides bind target proteins to guide design, screening and optimization; Borui Cuanghe contributes radiopharmaceutical development, radiolabeling and clinical translation, and the two sides iterate AI design against experimental validation. The target ligands must combine high affinity, high selectivity and good developability, and the work is at the collaboration-launch stage.

MindRank and Tencent Health announced a technical collaboration at the 2026 Tencent Global Digital Ecosystem Summit to bring MindRank's in-house Intera life-science foundation model into Tencent's one-stop life-science AI workbench, built on WorkBuddy. As one of the workbench's first ecosystem partners, MindRank plans to fold Intera into drug R&D workflows spanning target discovery, molecular design, virtual screening, automated synthesis, biological testing and clinical research, adding models versed in multiple drug modalities. The two sides will also explore structured return of experimental and clinical data to build a clinical data-in-the-loop cycle that keeps iterating the models.

MindRank and Tencent Health announced a technical collaboration at the 2026 Tencent Global Digital Ecosystem Summit to bring MindRank's in-house Intera life-science foundation model into Tencent's one-stop life-science AI workbench, built on WorkBuddy. As one of the workbench's first ecosystem partners, MindRank plans to fold Intera into drug R&D workflows spanning target discovery, molecular design, virtual screening, automated synthesis, biological testing and clinical research, adding models versed in multiple drug modalities. The two sides will also explore structured return of experimental and clinical data to build a clinical data-in-the-loop cycle that keeps iterating the models.